Subgroup | Studies | Participants | Intervention effect (min/day), MD (95% CI, I2) |
---|---|---|---|
Sex* | |||
Men | 2 | 434 | −57.94 (−86.14 to −29.74; 0%) |
Women | 10 | 1541 | −5.97 (−23.51 to 11.57; 33%) |
Men/women | 22 | 3893 | −25.32 (−42.94 to −7.69; 83%) |
Intervention duration† | |||
≤3 months | 14 | 1474 | −47.51 (−76.57 to −18.46; 81%) |
3–6 months | 11 | 2119 | −15.20 (−33.08 to 2.68; 67%) |
>6 months | 9 | 2275 | 0.30 (−17.83 to 18.44; 61%) |
Follow-up duration‡ | |||
<3 months | 17 | 1954 | −42.17 (−67.31 to −17.02; 84%) |
3–6 months | 13 | 2489 | −22.29 (−41.61 to −2.96; 77%) |
7–12 months | 11 | 2327 | −26.60 (−45.95 to −7.24; 73%) |
>12 months | 5 | 1264 | −3.06 (−34.05 to 27.94; 83%) |
Intervention setting‡ | |||
Workplace | 8 | 1790 | −8.93 (−26.64 to 8.78; 66%) |
Other | 26 | 4078 | −28.21 (−46.34 to −10.09; 80%) |
Assessment tool‡ | |||
activPAL | 2 | 67 | −45.37 (−87.99 to −2.74; 76%) |
Actigraph | 4 | 334 | −27.93 (−70.71 to 14.85; 75%) |
Sitting time questionnaire | 12 | 2576 | −10.92 (−30.59 to 8.74; 57%) |
Proxy measure questionnaire | 17 | 2983 | −29.39 (−50.56 to −8.21; 84%) |
Intervention aim‡ | |||
SB Primary outcome | 14 | 2258 | −24.05 (−45.43 to −2.67; 73%) |
SB Secondary outcome | 22 | 3764 | −23.17 (−40.02 to −6.32; 80%) |
*statistically significant subgroup difference at p<0.01.
†statistically significant subgroup difference at p <0.05.
‡non-significant subgroup difference.
SB, sedentary behaviour.